Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 10/21/2012 |
| Start Date: | May 2012 |
An Open Label Safety and Exploratory Efficacy Study of Kanglaite Injection in Patients Having Progressive Stage IV NSCLC Who Are Not Candidates for Other Anti-cancer Treatment
This study is for patients with advanced non small cell lung cancer that has progressed
despite standard of care. The purpose of the study is to see if Kanglaite injection has any
effect on survival.
Inclusion Criteria:
- confirmed (within last 3 months)progressive Stage IV NSCLC
- estimated life span of 3 months
- phase angle of at least 5 as measured by bioimpedance
Exclusion Criteria:
- currently taking a lipid lowering medications
- has an imminently life threatening condition
- has pre-existing liver disease
- known allergy to soybeans
- uncontrolled diabetes or uncontrolled disturbance of lipid metabolism
- pregnant or lactating
- has a pacemaker or other implantable electronic medical device
We found this trial at
3
sites
The West Clinic, PC Hello and welcome to our office. Although it is our pleasure...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials